Conavi Medical Completes First US Placement, Clinical Cases With Hybrid Imaging System

01:29 PM EST, 11/02/2026 (MT Newswires) -- Conavi Medical (CNVI.V) has completed the first US placement and clinical cases with its hybrid intravascular imaging system, the company said on Monday. The placement and first cases marked a milestone in Conavi's US commercial rollout following clearance by the US Food and Drug Administration. Conavi's Octiv combines intravascular ultrasound (IVUS) and optical coherence tomography (OCT) in a single imaging catheter, providing simultaneous views of coronary arteries to support assessment of coronary artery disease and guide percutaneous coronary intervention (PCI), a statement said. The company's shares were last seen up CA$0.01 at CA$0.12 on the TSX Venture Exchange. Price: 0.12, Change: +0.01, Percent Change: +9.09